Anticoagulant reversal drugs are required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding.
This report contains market size and forecasts of Anticoagulant Reversal Drug in global, including the following market information:
Global Anticoagulant Reversal Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Anticoagulant Reversal Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Anticoagulant Reversal Drug companies in 2021 (%)
The global Anticoagulant Reversal Drug market was valued at 1486.6 million in 2021 and is projected to reach US$ 2265.2 million by 2028, at a CAGR of 6.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prothrombin Complex Concentrates Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anticoagulant Reversal Drug include Bausch Health Companies, Pfizer, Fresenius Kabi, Amneal Pharmaceuticals, Boehringer Ingelheim, CSL, Octapharma, Portola Pharmaceuticals and Perosphere Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anticoagulant Reversal Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anticoagulant Reversal Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anticoagulant Reversal Drug Market Segment Percentages, by Type, 2021 (%)
Prothrombin Complex Concentrates
Vitamin K
Protamine
Tranexamic Acid
Global Anticoagulant Reversal Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anticoagulant Reversal Drug Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Others
Global Anticoagulant Reversal Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anticoagulant Reversal Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anticoagulant Reversal Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Anticoagulant Reversal Drug revenues share in global market, 2021 (%)
Key companies Anticoagulant Reversal Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Anticoagulant Reversal Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bausch Health Companies
Pfizer
Fresenius Kabi
Amneal Pharmaceuticals
Boehringer Ingelheim
CSL
Octapharma
Portola Pharmaceuticals
Perosphere Pharmaceuticals